Revenue surged by 15.6% year over year to $2.91 billion. Non-GAAP earnings per share of $3.98 missed expectations. R&D and SG&A expenses rose by 22.9%, impacting operating margins. Revenue $2.91 ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

to the countries embracing the DRM standard and their millions of listeners.” James Careless is an award-winning freelance journalist with experience in radio/TV broadcasting as well as A/V equipment, ...

Scott Mills said he is still finding it “quite hard to process that this is happening” as he began hosting the Radio 2 Breakfast Show on Monday morning. The 51-year-old has taken over from Zoe ...

Fans of Radio 2 flocked to social media website X this morning as some delivered their damning review of Scott Mills' BBC Radio 2 show. A few listeners said they were disappointed with his song ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Zoe Ball is set to return to BBC Radio 2 with a "new show". The presenter hosted her final Breakfast Show last month after announcing she would be stepping down from the role in November ...

Mills pictured with Tina Daheley (left), Ellie Brennan and a cake in the shape of an alarm clock DJ Scott Mills said he felt "really overwhelmed" as he welcomed listeners to his first BBC Radio 2 ...

Fans of BBC Radio 2 were finally treated to Scott Mills' first official day on his breakfast show and he made a bold promise. Taking to the airwaves at 6.30am, Scott gave an emphatic speech as he ...

Scott Mills says he is “not worried” about the perception that there are fewer women on BBC Radio 2 as he takes over the breakfast show from Zoe Ball. Ball signed off from her last show on ...

Vertex Pharmaceuticals performed well for much of 2024. In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful lumbosacral ...

A tentative settlement of the counter suit was reached in July of last year where the city agreed to pay Teichert $2.3 million that was owed for work on the water-meter project. The city’s ...